Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: Journal of Medical Internet Research

Date Submitted: Nov 28, 2025
Open Peer Review Period: Dec 1, 2025 - Jan 26, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Machine Learning–Based First-Trimester Antenatal Risk Prediction for Adverse Maternal and Neonatal Outcomes: A Multicenter Model Development Study

  • Sarah Li; 
  • David Y.Y. Tan; 
  • Jingxian Zhang; 
  • Aniza P. Mahyuddin; 
  • Sebastian E. Illanes; 
  • Max Monckeberg; 
  • Alejandra F. Plaza; 
  • Maria Paz Morgan L.; 
  • Matthew W. Kemp; 
  • Kee Yuan Ngiam; 
  • Peter Lindgren; 
  • Marius Kublickas; 
  • Karolina Kublickiene; 
  • Ruifen Weng; 
  • Sidney Yee; 
  • Mahesh Choolani

ABSTRACT

Background:

Maternal outcomes remain inequitable worldwide. Severe morbidity persists, and current risk assessment tools are largely arbitrary, focusing on biomedical factors while overlooking social determinants of health. There is a need for data-driven, artificial intelligence (AI) models to improve early pregnancy risk identification and management.

Objective:

To develop and internally validate first-trimester AI-based antenatal risk assessment models across three geographically and socio-ethnically diverse populations (Sweden, Chile, and Singapore), and to compare their performance against existing clinical risk assessment strategies.

Methods:

Retrospective population-based data from over 500,000 pregnancies from Sweden, Chile, and Singapore were used to develop Machine learning (ML) models predicting a composite of adverse maternal and neonatal outcomes. Models were trained and validated separately for each population using first-trimester variables. Model discrimination, measured by the area under the receiver operating characteristic (AUROC) curve, was compared with corresponding real-world first trimester risk assessment approaches.

Results:

The prevalence of the composite adverse outcome was 10.4% (75,647/727,354) in Sweden, 21.9% (1,302/5,934) in Chile, and 16.3% (6,165/37,813) in Singapore. In Sweden, the guideline-based risk assessment achieved an AUROC of 0.53, compared with 0.65 for the LightGBM model (P<.001). In Chile, the midwifery-led risk assessment achieved an AUROC of 0.52, versus 0.66 from the Traditional ML CatBoost model (P<.001). In Singapore, healthcare professional-based risk assessment reached an AUROC of 0.56, compared with 0.60 for the LightGBM model (P<.05). In the Swedish and Singapore, sociodemographic variables were among the most influential predictive features.

Conclusions:

AI-based models developed using first-trimester data surpassed that of existing first-trimester clinical risk stratification strategies across all three distinct populations. These findings highlight the potential of integrating social, demographic, and behavioural determinants into AI-driven, clinician-augmented antenatal care frameworks to promote more equitable and personalized pregnancy risk assessment.


 Citation

Please cite as:

Li S, Tan DY, Zhang J, Mahyuddin AP, Illanes SE, Monckeberg M, Plaza AF, Morgan L. MP, Kemp MW, Ngiam KY, Lindgren P, Kublickas M, Kublickiene K, Weng R, Yee S, Choolani M

Machine Learning–Based First-Trimester Antenatal Risk Prediction for Adverse Maternal and Neonatal Outcomes: A Multicenter Model Development Study

JMIR Preprints. 28/11/2025:88450

DOI: 10.2196/preprints.88450

URL: https://preprints.jmir.org/preprint/88450

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.